Cost-effectiveness of stereotactic body radiotherapy versus conventional radiotherapy for the treatment of surgically ineligible stage I non-small cell lung cancer in the Brazilian public health system

• Autors principals: Gustavo Viani Arruda (Autor), Marina Lourenção (Autor), Jorge Henrique Caldeira de Oliveira (Autor), Julia Simões Correa Galendi (Autor), Alexandre Arthur Jacinto (Autor)
• Format: Llibre
• Publicat: Elsevier, 2022-10-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

Summary: Background: The Brazilian public health system does not pay for the use of Stereotactic body radiotherapy (SBRT) due to its costs and the absence of cost-effectiveness analysis showing its benefit. The present study aims to evaluate whether the SBRT is a more cost-effective strategy than th...